0001209191-18-038073.txt : 20180615 0001209191-18-038073.hdr.sgml : 20180615 20180615163234 ACCESSION NUMBER: 0001209191-18-038073 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180614 FILED AS OF DATE: 20180615 DATE AS OF CHANGE: 20180615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LaPlaca Anthony CENTRAL INDEX KEY: 0001453022 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15103 FILM NUMBER: 18902606 MAIL ADDRESS: STREET 1: ONE INVACARE WAY CITY: ELYRIA STATE: OH ZIP: 44035 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INVACARE CORP CENTRAL INDEX KEY: 0000742112 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 952680965 STATE OF INCORPORATION: OH FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE INVACARE WAY STREET 2: P O BOX 4028 CITY: ELYRIA STATE: OH ZIP: 44036 BUSINESS PHONE: 4403296000 MAIL ADDRESS: STREET 1: ONE INVACARE WAY STREET 2: P O BOX 4028 CITY: ELYRIA STATE: OH ZIP: 44036 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-06-14 0 0000742112 INVACARE CORP IVC 0001453022 LaPlaca Anthony ONE INVACARE WAY ELYRIA OH 44035 0 1 0 0 Sr. VP and General Counsel Common Shares 2018-06-14 4 M 0 20000 16.55 A 64385 D Common Shares 2018-06-14 4 S 0 20000 19.591 D 44385 D Employee Stock Option (Right to Buy) 16.55 2018-06-14 4 M 0 20000 0.00 D 2018-10-27 Common Shares 20000 66700 D Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.507 - $19.675. The reporting person hereby undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. This option vested equally on September 30, 2009, 2010, 2011 and 2012. The reporting person holds previously reported options to buy 66,700 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between August 19, 2009 and March 18, 2013, at exercise prices between $13.37 to $25.24 per share, will expire between August 19, 2019 and March 18, 2023, and became exercisable between September 30, 2010 and March 31, 2017. /s/ Anthony C. LaPlaca, by Kristofer K. Spreen, his attorney-in-fact, pursuant to Power of Attorney, dated December 30, 2008, on file with the Commission 2018-06-15